Hyperammonemia (Acquired)
Overview
Plain-Language Overview
Hyperammonemia (Acquired) is a condition where there is too much ammonia in the blood, which is harmful to the brain. Ammonia is a waste product normally removed by the liver through a process called the urea cycle. When the liver is damaged or overwhelmed, ammonia builds up and can cause symptoms like confusion, vomiting, and even coma. This condition mainly affects the nervous system because ammonia is toxic to brain cells. Causes include severe liver disease, certain infections, or medications that impair ammonia clearance. Early recognition is important because high ammonia levels can lead to serious brain swelling and permanent damage.
Clinical Definition
Hyperammonemia (Acquired) is defined as an elevated blood ammonia concentration due to impaired hepatic clearance or increased ammonia production outside of inherited urea cycle defects. The core pathology involves disruption of the urea cycle in the liver, leading to accumulation of neurotoxic ammonia. Common causes include acute or chronic liver failure, portosystemic shunting, infections with urease-producing organisms, and certain drugs like valproate. The condition is clinically significant because elevated ammonia crosses the blood-brain barrier, causing cerebral edema, encephalopathy, and potentially fatal neurological dysfunction. Diagnosis requires recognition of elevated ammonia in the context of liver dysfunction or other precipitating factors. Prompt identification is critical to prevent irreversible brain injury.
Inciting Event
Acute liver injury from toxins, viral hepatitis, or ischemia.
Gastrointestinal bleeding increasing nitrogen absorption.
Infections or sepsis triggering systemic inflammation and catabolism.
High protein diet or excessive protein catabolism during stress or trauma.
Use of hepatotoxic drugs or medications impairing ammonia metabolism.
Latency Period
Hours to days after acute liver insult or precipitating event.
Rapid onset in acute liver failure, often within 24-72 hours.
Variable delay in chronic liver disease depending on precipitating factors.
Progressive worsening over days if untreated.
Immediate symptoms may appear after gastrointestinal bleeding or infection.
Diagnostic Delay
Nonspecific neuropsychiatric symptoms often misattributed to other causes like intoxication or metabolic encephalopathy.
Lack of routine ammonia measurement in altered mental status evaluation.
Overlap with other causes of encephalopathy such as hypoglycemia or electrolyte disturbances.
Failure to recognize precipitating factors like GI bleeding or infection.
Delayed liver function testing or imaging to identify hepatic dysfunction.
Clinical Presentation
Signs & Symptoms
Confusion and decreased attention
Lethargy progressing to stupor or coma
Nausea and vomiting due to metabolic disturbance
Seizures in severe hyperammonemia
Behavioral changes such as irritability or agitation
History of Present Illness
Progressive confusion, lethargy, and altered mental status often developing over hours to days.
Asterixis (flapping tremor) as a hallmark neurologic sign.
Nausea, vomiting, and anorexia preceding encephalopathy in some cases.
Preceding events such as gastrointestinal bleeding or infection reported by patient or family.
Rapid deterioration to coma in severe cases without treatment.
Past Medical History
Chronic liver disease or cirrhosis documented by prior imaging or biopsy.
History of alcohol use disorder or viral hepatitis infection.
Previous episodes of hepatic encephalopathy or hyperammonemia.
Use of medications affecting liver function or ammonia metabolism such as valproate.
Recent gastrointestinal bleeding, surgery, or infection increasing ammonia load.
Family History
Usually negative for inherited urea cycle disorders in acquired hyperammonemia.
Family history of liver disease such as cirrhosis or hepatitis may be present.
Rarely, family history of metabolic disorders affecting ammonia metabolism may be relevant.
No consistent familial pattern in typical acquired cases.
Family history of alcohol use disorder or viral hepatitis may increase risk indirectly.
Physical Exam Findings
Asterixis (flapping tremor) indicating hepatic encephalopathy
Altered mental status ranging from confusion to coma
Hyperreflexia or increased deep tendon reflexes
Jaundice if underlying liver disease is present
Tachypnea due to metabolic encephalopathy
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by measuring serum ammonia levels, which are elevated above the normal range (typically >50 µmol/L). Clinical correlation with signs of hepatic encephalopathy or altered mental status in a patient with known or suspected liver disease supports the diagnosis. Additional tests include liver function tests showing elevated transaminases or synthetic dysfunction, and imaging to exclude other causes of encephalopathy. Identification of precipitating factors such as infection or medication use is important. Confirmatory diagnosis relies on excluding inherited urea cycle disorders and demonstrating acquired impairment of ammonia metabolism.
Pathophysiology
Key Mechanisms
Impaired hepatic urea cycle function leading to accumulation of ammonia in the blood.
Liver dysfunction causing decreased conversion of ammonia to urea and subsequent systemic toxicity.
Portosystemic shunting allowing ammonia-rich blood to bypass hepatic metabolism and enter systemic circulation.
Increased ammonia production from gut bacteria or catabolism of nitrogenous compounds during critical illness.
Neurotoxicity from elevated ammonia causing astrocyte swelling, cerebral edema, and altered neurotransmission.
| Involvement | Details |
|---|---|
| Organs | Liver is the central organ for ammonia detoxification via the urea cycle and is often impaired in acquired hyperammonemia. |
Kidneys contribute to ammonia excretion and are involved in alternative nitrogen disposal pathways. | |
Brain is the target organ for ammonia toxicity, leading to symptoms of encephalopathy and cerebral edema. | |
| Tissues | Intestinal mucosa is a major site of ammonia production from bacterial metabolism of nitrogenous compounds. |
Brain tissue is affected by ammonia toxicity causing astrocyte swelling and encephalopathy. | |
| Cells | Hepatocytes are the primary cells responsible for ammonia detoxification via the urea cycle. |
Astrocytes in the brain metabolize ammonia to glutamine, contributing to cerebral edema in hyperammonemia. | |
| Chemical Mediators | Ammonia is the toxic metabolite that accumulates and causes neurological dysfunction in hyperammonemia. |
Glutamine accumulates in astrocytes leading to osmotic swelling and cerebral edema. | |
Urea cycle enzymes regulate ammonia detoxification in the liver. |
Treatments
Pharmacological Treatments
Lactulose
- Mechanism:
Acidifies the colon to convert ammonia to nonabsorbable ammonium, reducing systemic absorption.
- Side effects:
Diarrhea
Electrolyte imbalance
Abdominal cramping
- Clinical role:
First-line
Rifaximin
- Mechanism:
Nonabsorbable antibiotic that decreases intestinal ammonia-producing bacteria.
- Side effects:
Nausea
Flatulence
Headache
- Clinical role:
Adjunctive
Sodium benzoate
- Mechanism:
Binds glycine to form hippurate, which is excreted renally, removing nitrogen.
- Side effects:
Hypokalemia
Metabolic acidosis
Nausea
- Clinical role:
Second-line
Arginine
- Mechanism:
Supplies substrate for urea cycle to enhance ammonia detoxification in liver.
- Side effects:
Hyperkalemia
Hypotension
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Implement dietary protein restriction to reduce ammonia production from gut metabolism.
Provide supportive care including hydration and correction of electrolyte imbalances.
Use hemodialysis or continuous renal replacement therapy in severe cases to rapidly remove ammonia.
Treat underlying causes such as liver failure or gastrointestinal bleeding promptly.
Prevention
Pharmacological Prevention
Lactulose to reduce ammonia absorption in the gut
Rifaximin as an antibiotic to decrease ammonia-producing gut bacteria
Neomycin as an alternative antibiotic for gut flora modification
L-ornithine L-aspartate to enhance ammonia detoxification
Zinc supplementation to support urea cycle enzyme function
Non-pharmacological Prevention
Protein restriction to reduce ammonia production
Avoidance of sedatives that worsen encephalopathy
Prompt treatment of infections to prevent precipitating hyperammonemia
Management of gastrointestinal bleeding to reduce nitrogen load
Regular monitoring of liver function and ammonia levels in at-risk patients
Outcome & Complications
Complications
Cerebral edema leading to increased intracranial pressure
Hepatic encephalopathy with progressive neurological decline
Seizures and status epilepticus
Respiratory failure due to decreased consciousness
Death if untreated or severe
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Hyperammonemia (Acquired) versus Urea Cycle Disorder (Inherited)
Hyperammonemia (Acquired) | Urea Cycle Disorder (Inherited) |
|---|---|
Adult or late-onset hyperammonemia after liver injury or illness | Neonatal or early childhood presentation with hyperammonemia |
No inheritance pattern; acquired due to liver dysfunction or toxins | X-linked or autosomal recessive inheritance pattern |
Elevated ammonia with normal orotic acid and variable amino acid profile | Elevated plasma glutamine and orotic acid with low citrulline |
Liver function tests and imaging indicating hepatic dysfunction | Enzyme assay or genetic testing showing urea cycle enzyme deficiency |
Hyperammonemia (Acquired) versus Hepatic Encephalopathy
Hyperammonemia (Acquired) | Hepatic Encephalopathy |
|---|---|
No chronic liver disease; hyperammonemia due to other causes | Chronic liver disease or cirrhosis history |
Progressive encephalopathy without typical precipitating events | Fluctuating mental status with precipitating factors like GI bleeding or infection |
Elevated ammonia with normal or mildly abnormal liver enzymes | Elevated ammonia with abnormal liver function tests (elevated AST, ALT, bilirubin) |
No imaging evidence of chronic liver disease | Signs of cirrhosis or portal hypertension on abdominal ultrasound or CT |
Hyperammonemia (Acquired) versus Valproic Acid Toxicity
Hyperammonemia (Acquired) | Valproic Acid Toxicity |
|---|---|
No valproic acid exposure | Recent or ongoing valproic acid use |
Normal valproic acid levels or absent drug | Elevated serum valproic acid levels with hyperammonemia |
Gradual onset related to liver dysfunction or other causes | Rapid onset of encephalopathy after valproic acid initiation or dose increase |
Hyperammonemia (Acquired) versus Reye Syndrome
Hyperammonemia (Acquired) | Reye Syndrome |
|---|---|
Adults or any age with acquired hyperammonemia without aspirin exposure | Children and adolescents after viral illness and aspirin use |
No aspirin exposure or viral prodrome | Recent viral infection and aspirin use |
Elevated ammonia with variable glucose and liver enzyme levels | Elevated ammonia with hypoglycemia and elevated liver enzymes |
Variable liver pathology depending on cause of hyperammonemia | Microvesicular steatosis on liver biopsy |
Hyperammonemia (Acquired) versus Inborn Errors of Metabolism (Other than Urea Cycle)
Hyperammonemia (Acquired) | Inborn Errors of Metabolism (Other than Urea Cycle) |
|---|---|
Often adult or acquired onset | Typically presents in infancy or early childhood |
Isolated hyperammonemia without other metabolite abnormalities | Specific metabolite accumulation (e.g., organic acids, amino acids) on metabolic panel |
No inherited metabolic enzyme deficiency identified | Enzyme assays or genetic testing confirming specific metabolic defect |